Monday, March 30, 2009

Amgen to Present at the Citigroup Biotech Day

THOUSAND OAKS, Calif. – March 30 – Amgen (Nasdaq: AMGN) will present at Citigroup’s 4th Annual Biotech Day on Wednesday, April 1, 2009 at the Citigroup Conference Center, New York, N.Y., beginning at 11:20 a.m. Eastern Time. Amgen Vice President of Investor Relations Arvind Sood will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s Web site, http://www.amgen.com, under Investors.

Read the rest of this entry

Posted in Press Releases

Tuesday, March 17, 2009

Amgen’s Statement in Response to the Eshoo/Inslee/Barton Bill to Establish a Pathway for the Approval of Biosimilars

The following statement was issued today by Amgen regarding legislation introduced today by Representatives Eshoo, Inslee and Barton to establish a pathway for the approval of biosimilars.

The legislation introduced by Representatives Eshoo, Inslee and Barton appears to strike a necessary balance in allowing access to safe and effective biosimilar medicines for patients, and providing fair incentives for the discovery of new medicines for serious diseases.

Read the rest of this entry

Posted in Company Statements

Monday, March 16, 2009

Amgen to Present at the Cowen and Company Annual Healthcare Conference

THOUSAND OAKS, Calif.-(BUSINESS WIRE)–March 16, 2009

Amgen (NASDAQ:AMGN) will present at the Cowen and Company Annual Healthcare Conference on Wednesday, March 18, 2009 at the Boston Marriott Copley Place, Boston, Mass., beginning at 9:30 a.m. Eastern Time.

Read the rest of this entry

Posted in Press Releases

Wednesday, March 11, 2009

Statement in Response to Chairman Waxman and Senator Schumer's Bill to Establish a Pathway for the Approval of Biosimilars

As a pioneer in developing first-in-class medicines that treat serious illnesses and address unmet health needs, Amgen believes that an abbreviated biosimilar approval pathway must not discourage the development of groundbreaking new treatments for serious diseases.

Read the rest of this entry

Posted in Company Statements

Monday, March 09, 2009

Amgen to Present at the Barclays Capital Global Healthcare Conference

THOUSAND OAKS, Calif. – March 9 – Amgen (Nasdaq: AMGN) will present at the Barclays Capital Global Healthcare Conference on Wednesday, March 11, 2009 at the Loews Miami Beach Hotel, Miami Beach, Fla., beginning at 9:00 a.m. Eastern Time. Amgen’s Chief Financial Officer Robert A. Bradway will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen’s Web site, http://www.amgen.com, under Investors.

Read the rest of this entry

Posted in Press Releases